GRIFOLS | GRF - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Alcon AG USD 22.13B 99M 2026-03
Almirall EUR 1.49B 24.03M 2025-12
Amadeus IT EUR 4.8B 49.7M 2026-03
Amarin USD 449.41M 9.87M 2026-03
argenx SE USD 7.32B 1.23B 2025-12
AstraZeneca USD 47.33B 1.33B 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Cie Automotive EUR 1.45B 46.93M 2025-12
Demant DKK 9.84B 446M 2025-12
Ence Energia y Celulosa EUR 496.44M 106.36M 2025-12
Essilor EUR 38.89B 1.07B 2025-12
Ferrovial EUR 7.66B 11M 2025-12
Fresenius EUR 19.77B 1.14B 2025-12
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Genmab DKK 5.85B 96M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Inditex 18.8B 1.84B 2025-09
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Merck EUR 29.74B 1.15B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Philips EUR 11.39B 403M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Smith & Nephew USD 5.54B 331M 2025-12
UCB EUR 10.87B 1.18B 2025-12
Viscofan EUR 932.04M 4.41M 2026-03